PBM vs. ISPO, NMHI, OPTX, ZOOZ, CERO, NVNI, QFTA, BENF, RWOD, and EFHT
Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Inspirato (ISPO), Nature's Miracle (NMHI), Syntec Optics (OPTX), ZOOZ Power (ZOOZ), CERo Therapeutics (CERO), Nvni Group (NVNI), Quantum FinTech Acquisition (QFTA), Beneficient (BENF), Redwoods Acquisition (RWOD), and EF Hutton Acquisition Co. I (EFHT). These companies are all part of the "holding & other investment offices" industry.
Psyence Biomedical (NASDAQ:PBM) and Inspirato (NASDAQ:ISPO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations, media sentiment and community ranking.
Inspirato has a consensus price target of $10.50, suggesting a potential upside of 159.26%. Given Inspirato's higher possible upside, analysts clearly believe Inspirato is more favorable than Psyence Biomedical.
Inspirato received 5 more outperform votes than Psyence Biomedical when rated by MarketBeat users.
Psyence Biomedical has higher earnings, but lower revenue than Inspirato.
In the previous week, Psyence Biomedical and Psyence Biomedical both had 2 articles in the media. Psyence Biomedical's average media sentiment score of 0.62 beat Inspirato's score of 0.43 indicating that Psyence Biomedical is being referred to more favorably in the media.
77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 39.5% of Inspirato shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by company insiders. Comparatively, 34.2% of Inspirato shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Psyence Biomedical has a net margin of 0.00% compared to Inspirato's net margin of -14.98%.
Psyence Biomedical has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Inspirato has a beta of -0.1, meaning that its share price is 110% less volatile than the S&P 500.
Summary
Inspirato beats Psyence Biomedical on 6 of the 10 factors compared between the two stocks.
Get Psyence Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PBM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Psyence Biomedical Competitors List
Related Companies and Tools
